Director of Research (DR2) Inserm
Head of the team “Physiology and physiopathology of the urogenital tract”, Irset-Inserm UMR 1085 (Rennes, France)
2008............. HDR (Certification of supervisory ability for PhD students), Rennes 1 University
1997............. Doctorate in Cellular and Molecular Biology, Rennes 1 University
1993............. Master of Advanced Studies (DEA) in Cellular and Molecular Biology, Rennes 1 University
1992............. Master in Biochemistry, Rennes 1 University
2012-present.. Team leader, Institute of Research on Health, Environment and Occupation (Irset – Inserm UMR 1085). Rennes, France
2011-present.. Director of Research (DR2) Inserm
2004-2011..... Senior scientist (CR1) Inserm, Inserm U 625, Rennes, France, co-team leader
2000-2004..... Research scientist (CR2) Inserm, Inserm U435, Rennes, France
1998-2000..... Research Scientist, University College London, London, UK
1997-1998..... Post-doctorate (Inserm awardee), Institute of Cancer Research, London, UK
1993-1997..... Doctorate, Inserm U435, Rennes, France
2015-............ Member of the ANRS scientific committee “Host-virus interactions in HIV infection” (CSS1)
2013............. Member of the Inserm selecting committee for clinicians “Contrats d’interface hospitalier”
2008-2012..... Member of the Inserm commitee for researchers recruitment and promotion (CSS4)
2011............. Member of University selecting committees for lecturers
2013-present.. Member of the Scientific Advisory board of the French Research group on Reproduction.
2013............. Member of the selecting committee for the Prix Bretagne Jeune Chercheur
2012-present.. Member of the Commission Recherche Ecole Doctorale Vie-Agro-Santé, Rennes
2010-2012..... Member of the University Scientific advisory board UFR SVE, Rennes
2009............. Member of the Ministry of research workgroup “Secrétions et pharmacologie génitales” (Mission ministérielle Prévention et Réduction des risques dans les groupes à haut risques vis-à-vis du VIH et des IST)
2009............. Member of the workgroup “Etat des lieux et évolution de la recherche en Reproduction” (Institut thématique Génétique et Développement)
2009-present.. Member of the Scientic Advisory board “Espace des Sciences”, Rennes: organization of scientifc seminar for the general public
2007-present.. Co-leader of the scientific animation committee “Agents pathogènes et maladies infectieuses” (SFR Biosit, Rennes)
2007-present.. Member of the ANRS workgroup “Modèles primates non humains” and “Réservoirs”
Grant reviewing activities: ANR (expert and comittee member), Agence Nationale de Biomédecine, Fond de dotation P. Bergé-Sidaction, South African Medical Research Council, SFR ScInBioS, DIM cellules souches région Ile de France.
Reviewing for international journals and conferences: AIDS, Faseb J, Retrovirology, Antiviral therapy, Human Reproduction, Journal of General Virology, PLoS One, Journal of Andrology, AIDS Human retroviruses, Reproduction, Systems biology in Reproductive Medicine, Open AIDS journal, Theriogenology, International AIDS conference.
Member of 11 thesis and HDR juries, as well as Master 2 and doctoral school juries.
2000-present.... Supervision of 8 PhD students, 3 post-doctorates, 13 Master 2 students, 10 Master 1 and L3 students.
2004-present.... Teaching: Diploma of specialized study for medical students; Master 2 Biologie-Santé, Rennes 1 University; Master 1 Biologie Cellulaire & Physiologie, Rennes 1 University; European Doctoral College on Environment and Health (EDCEH), Rennes University.
My team studies the consequences of exposures to viruses and chemicals (environmental and pharmaceuticals) on the urogenital tract health and on fertility.
Our objectives are to address major health concerns related to the urogenital tract, namely: (i) the sexual dissemination of viruses, and the consequences of viral infections of the urogenital tract on fertility and cancers ; (ii) the increase of male urogenital tract abnormalities (testis cancer, hypospadias and cryptorchidism), which can lead to infertility, as well as the increase of medical consultations for ovarian deficiency ; (iii) the potential deleterious effects of anti-cancer treatments on fertility.
Our researches are developed according to 4 axes:
In the frame of our researches, we are also committed to the development of innovative tools in bio-informatics, cellular and molecular biology.
For more detail, www.irset.org